Catapult Capital Management’s Pfizer PFE Stock Holding History

Catapult Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.82M	Buy	+94,657	New	+$3.04M	1.07%	25
2015 Q2	–	Sell	-544,590	Closed	-$18M	–	271
2015 Q1	$18M	Buy	544,590 +162,922	+43%	+$5.18M	2.2%	5
2014 Q4	$11.3M	Buy	381,668 +302,618	+383%	+$8.68M	2.87%	3
2014 Q3	$2.22M	Buy	+79,050	New	+$2.22M	0.24%	121
2014 Q2	–	Sell	-144,255	Closed	-$4.4M	–	237
2014 Q1	$4.4M	Buy	+144,255	New	+$4.3M	0.88%	27

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Catapult Capital Management's PFE Position: Q3 2015 in Review

Catapult Capital Management opened a new position in Pfizer (PFE) in Q3 2015: 94,657 shares worth $2.82M. The stake represents 1.07% of the portfolio and ranks #25 among its holdings. This is a return to the name: Catapult Capital Management previously reported a position in PFE as recently as Q1 2015.

Catapult Capital Management first reported a position in PFE in Q1 2014 and has held it in 5 quarters since. The position peaked at $18M in Q1 2015. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Catapult Capital Management held 94,657 shares of Pfizer worth $2.82M as of Q3 2015.
Pfizer was a new Catapult Capital Management position in Q3 2015.
Pfizer made up 1.07% of Catapult Capital Management's portfolio in Q3 2015, its #25 holding.
Catapult Capital Management first reported a position in Pfizer in Q1 2014 and has held it in 5 quarters since.
Catapult Capital Management's Pfizer position peaked at $18M in Q1 2015.
1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.